- Home
- GTX vs NEO Comparison
GTX vs NEO Comparison
Compare GTX & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- NEO
- Stock Information
- Founded
- GTX 2018
- NEO 2001
- Country
- GTX Switzerland
- NEO United States
- Employees
- GTX N/A
- NEO N/A
- Industry
- GTX Auto Parts:O.E.M.
- NEO Precision Instruments
- Sector
- GTX Consumer Discretionary
- NEO Health Care
- Exchange
- GTX Nasdaq
- NEO Nasdaq
- Market Cap
- GTX 1.8B
- NEO 1.9B
- IPO Year
- GTX N/A
- NEO 1999
- Fundamental
- Price
- GTX $8.31
- NEO $16.39
- Analyst Decision
- GTX Strong Buy
- NEO Strong Buy
- Analyst Count
- GTX 1
- NEO 8
- Target Price
- GTX $12.00
- NEO $20.25
- AVG Volume (30 Days)
- GTX 869.0K
- NEO 746.6K
- Earning Date
- GTX 10-24-2024
- NEO 11-05-2024
- Dividend Yield
- GTX N/A
- NEO N/A
- EPS Growth
- GTX N/A
- NEO N/A
- EPS
- GTX 1.01
- NEO N/A
- Revenue
- GTX $3,576,000,000.00
- NEO $644,118,000.00
- Revenue This Year
- GTX N/A
- NEO $12.93
- Revenue Next Year
- GTX $3.10
- NEO $9.70
- P/E Ratio
- GTX $8.21
- NEO N/A
- Revenue Growth
- GTX N/A
- NEO 12.06
- 52 Week Low
- GTX $7.13
- NEO $12.77
- 52 Week High
- GTX $10.16
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- GTX 63.40
- NEO 66.29
- Support Level
- GTX $7.72
- NEO $15.00
- Resistance Level
- GTX $8.13
- NEO $16.60
- Average True Range (ATR)
- GTX 0.24
- NEO 0.72
- MACD
- GTX 0.07
- NEO 0.05
- Stochastic Oscillator
- GTX 89.72
- NEO 93.54
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.